Insider Selling: Delta 9 Cannabis Inc (CVE:NINE) Director Sells 80,000 Shares of Stock
Insider Selling: Delta 9 Cannabis Inc (CVE:NINE) Director Sells 80,000 Shares of Stock
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.Delta 9 Cannabis Inc (CVE:NINE – Get Rating) Director Hugh Housser Aird sold 80,000 shares of the business's stock in a transaction dated Friday, August 26th. The shares were sold at an average price of C$0.16, for a total value of C$13,112.00. Following the completion of the transaction, the director now owns 167,500 shares in the company, valued at approximately C$27,453.25.
德尔塔9号大麻公司(CVE：9-GET评级)董事休·豪塞尔·艾德在8月26日星期五的交易中出售了80,000股该公司股票。这些股票的平均价格为0.16加元，总价值为13,112.00加元。交易完成后，董事现在拥有该公司167,500股票，价值约27,453.25加元。
Hugh Housser Aird also recently made the following trade(s):
休·豪瑟·艾尔德最近还进行了以下交易：
- On Monday, August 22nd, Hugh Housser Aird sold 45,000 shares of Delta 9 Cannabis stock. The shares were sold at an average price of C$0.19, for a total value of C$8,338.50.
- 8月22日，星期一，休·豪泽航空公司出售了45,000股Delta 9大麻股票。这些股票的平均价格为0.19加元，总价值为8,338.50加元。
Delta 9 Cannabis Price Performance
Delta 9大麻的性价比
Delta 9 Cannabis stock opened at C$1.03 on Friday. The company has a debt-to-equity ratio of 33.00, a current ratio of 4.44 and a quick ratio of 2.04. The business has a 50 day simple moving average of C$1.03 and a 200-day simple moving average of C$1.03. Delta 9 Cannabis Inc has a 12 month low of C$0.92 and a 12 month high of C$2.35. The stock has a market capitalization of C$89.36 million and a PE ratio of 19.07.
Delta 9大麻股票周五开盘报1.03加元。该公司的债务权益比为33.00，流动比率为4.44，速动比率为2.04。该业务的50日简单移动均线切入位在1.03加元，200日简单移动均线切入位在1.03加元。Delta 9 Cannabis Inc.的12个月低点为0.92加元，12个月高位为2.35加元。该股市值为8936万加元，市盈率为19.07倍。
Delta 9 Cannabis Company Profile
Delta 9大麻公司简介
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.
Delta 9大麻公司是一家综合性大麻公司。该公司通过其子公司Delta 9 Bio-Tech Inc从事医用大麻的生产。它主要提供大麻品种，以及启动材料和支持服务，包括遗传学(植物)、种植豆荚，以及向新的和现有的获得许可的生产商提供咨询服务。
Recommended Stories
推荐故事
- Could Nike Stock be Oversold, but Still Overvalued?
- Is Alcoa A Buy After Strong Q2 Results And More Share Buybacks?
- Will Royal Caribbean's Broadband Partnership Drive Revenue?
- Chip Gear Maker Entegris Has Potential, But Is It Buyable Now?
- DocuSign Has Important Issues to Address When it Reports Earnings
- 耐克股票会被超卖，但仍被高估吗？
- 美国铝业是在第二季度业绩强劲和更多股票回购之后买入的吗？
- 皇家加勒比的宽带合作能否推动收入增长？
- 芯片设备制造商Entigis很有潜力，但它现在可以买下吗？
- DocuSign在报告收益时有重要的问题需要解决
Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
接受Delta 9大麻日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Delta 9大麻和相关公司的最新新闻和分析师评级的每日简要摘要。
